Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD005441.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 octubre 2009see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Hepatobiliar

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Tahany Awad

    Correspondencia a: Cochrane Hepato‐Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    [email protected]

  • Jesper Brok

    Cochrane Hepato‐Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

  • Kristian Thorlund

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

  • Goran Hauser

    Clinics of Internal Medicine ‐ Gastroenterology, Clinical Hospital Centre of Rijeka, Rijeka, Croatia

  • Davor Stimac

    Clinics of Internal Medicine ‐ Gastroenterology, Clinical Hospital Centre of Rijeka, Rijeka, Croatia

  • Mahasen Mabrouk

    Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt

  • Christian Gluud

    Cochrane Hepato‐Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

  • Lise Lotte Gluud

    Cochrane Hepato‐Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Contributions of authors

Tahany Awad drafted the protocol, will perform the literature search, will perform the data extraction, will assess the risk of bias in the included trials, will perform all statistical analyses that can be done in RevMan, will contribute to the interpretation of results, and will draft the review. Jesper Brok revised the protocol, will perform the data extraction, will asses the risk of bias in the included trials, will contribute to the interpretation of results, and will revise the review. Kristian Thorlund revised the protocol, will assess the risk of bias associated with incomplete outcome data, will perform all statistical analyses that could not be done in RevMan including TSA, will contribute to the interpretation of results, and will revise the review. Goran Hauser will perform the data extraction and asses the risk of bias in the included trials. Davor Stimac will contribute to the interpretation of results and will revise the review. Mahasen Mabrouk, Christian Gluud, and Lise Lotte Gluud revised the protocol, will act as an arbitrator for disagreements in data extraction and the bias risk assessment, will contribute to the interpretation of results, and will revise the review.

Sources of support

Internal sources

  • Copenhagen Trial Unit, Centre for Clinical Intervention Research, H:S Rigshospitalet, Denmark.

External sources

  • No sources of support supplied

Declarations of interest

None known.

Acknowledgements

Special thanks to Dimitrinka Nikolova for her advice, encouragement, and support during the preparation of this protocol. Thanks to Sarah Klingenberg for advising on search strategy. Thanks to Marija Simin for drafting the previous version of the protocol (Simin 2005).

Peer Reviewers: David Wong, USA; Christian Trepo, France; Zahari Krastev, Bulgaria; Anna Fracanzani, Italy.
Contact Editors: Ronald L Koretz, USA; Bodil Als‐Nielsen, Denmark.

Version history

Published

Title

Stage

Authors

Version

2014 Feb 28

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

Review

Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud

https://doi.org/10.1002/14651858.CD005441.pub3

2009 Oct 07

Pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C

Protocol

Tahany Awad, Jesper Brok, Kristian Thorlund, Goran Hauser, Davor Stimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud

https://doi.org/10.1002/14651858.CD005441.pub2

2009 Jul 08

Pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C

Protocol

Marija Simin, Jesper Brok, Davor Stimac, Christian Gluud, Lise Lotte Gluud

https://doi.org/10.1002/14651858.CD005441

Keywords

MeSH